Preparation of dopamine transporter-specific antibodies using molecular cloned genes

  • Shee -Yong Lee
  • Suhn -Young Im
  • Kyeong -Man Kim
Research Articles Microbiology & Immunology


Dopamine transporter (DAT) plays the most important role in terminating the actions of dopamines released into the synaptic cleft. DAT is also the target of various psychotropic drugs such as cocaine and amphetamine. In this study we prepared DAT-specific antibodies using the 2nd extracellular loop of rat DAT as an antigen. The 2nd extracellular loop of the rat DAT was expressed in bacteria as a fusion protein with glutathione-S-transferase, and injected into rabbits to raise antibodies. Produced antibodies clearly recognized the rat DAT in ELISA, immunoblotting, and immunoprecipitation. As expected from the high sequence homology between the rat and human DAT, the antibodies raised for the rat DAT crossreacted with the human DAT in the immunoblotting. Considering the specificity for DAT with wide range of applications such as ELISA, immunoblotting, and immunoprecipitation, these antibodies would be valuable tool for understanding the pharmacological actions of dopamine transporter and drug addiction.

Key words

Dopamine transporter Antibodies Drug addiction 

References Cited

  1. Cheong, J. S., Kim, A. Y. and Kim, K. M., Identification of certain sequences in the 3rd cytoplasmic loop of D4 dopamine receptor that suppress the bacterial expression.Arch. Pharm. Res., 19, 275–279 (1996).CrossRefGoogle Scholar
  2. Ciliax B. J., Heilman, C., Demchyshyn, L. L., Pristupa, Z. B., Ince, E., Hersch, S. M., Niznik, H. B. and Levey, A. I., The dopamine transporter: immunochemical characterization and localization in brain.J. Neurosci., 15, 1714–1723 (1995).PubMedGoogle Scholar
  3. Giros, B. el Mestikawy, S., Bertrand, L. and Caron, M. G., Cloning and functional characterization of a cocainesensitive dopamine transporter.FEBS Lett., 295, 149–154 (1991).PubMedCrossRefGoogle Scholar
  4. Giros, B., Jaber, M., Jones, S. R., Wightman, R. M. and Caron, M. G., Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter.Nature, 379, 606–612 (1996).PubMedCrossRefGoogle Scholar
  5. Grigoriadis, D. E., Wilson, A. A., Lew, R., Sharkey, J. S. and Kuhar, M. J., Dopamine transporter sites selectively labeled by a novel photoaffinity probe:125I DEEP.J. Neurosci. 9, 2664–2670 (1989).PubMedGoogle Scholar
  6. Kilty, J. E., Lorang, D. and Amara, S. G., Cloning and expression of a cocaine-sensitive rat dopamine transporter.Science, 254, 528–529 (1991).CrossRefGoogle Scholar
  7. Kim, A. E., Lee, S. Y. and Kim, K. M., Preparation of δ-opioid receptor-specific antibodies using molecular cloned genes.Arch. Pharm. Res. 18, 113–117 (1995).CrossRefGoogle Scholar
  8. Madras, B. K., Gracz, L. M., Meltzer, P. C., Liang, A. Y., Elmaleh, D. R., Kaufman, M. J. and Fischman, A. J., Altropane, a SPECT or PET imaging probe for dopamine neurons: II. Distribution to dopamine-rich regions of primate brain.Synapse 29, 105–115 (1998).PubMedCrossRefGoogle Scholar
  9. Patel, A., Uhl, G. and Kuhar, M. J., Species differences in dopamine transporters: postmortem changes and glycosylation differences.J. Neurochem., 61, 496–500 (1993).PubMedCrossRefGoogle Scholar
  10. Robinson, T. E. and Becker, J. B., Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis.Brain Res. 396, 157–198 (1986).PubMedCrossRefGoogle Scholar
  11. Shimada, S., Kitayama, S., Lin, C. L., Patel, A., Nanthakumar, E., Gregor, P., Kuhar, M. and Uhl, G., Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA.Science, 254, 576–587 (1991).PubMedCrossRefGoogle Scholar
  12. Snyder, S. H., Amphetamine psychosis: a “model” schizophrenia mediated by catecholamines.Am. J. Psychiatry, 130, 61–67 (1973).PubMedGoogle Scholar
  13. Vaughan, R. A., Photoaffinity-labeled ligand binding domains on dopamine transporters identified by peptide mapping.Mol. Pharmacol., 47, 956–964 (1995).PubMedGoogle Scholar

Copyright information

© The Pharmaceutical Society of Korea 1999

Authors and Affiliations

  • Shee -Yong Lee
    • 1
  • Suhn -Young Im
    • 2
  • Kyeong -Man Kim
    • 1
  1. 1.Pharmacology Laboratory, College of PharmacyChonnam National UniversityKwang-JuKorea
  2. 2.Department of Biology, College of Natural SciencesChonnam National UniversityKwang-JuKorea

Personalised recommendations